DOWNLOADABLE RESOURCES
DOWNLOADABLE RESOURCES
Explore the following resources to learn more about recent developments in the treatment of ES-SCLC.
ASTRUM-005 PUBLICATION
ASTRIDE TRIAL IN-PROGRESS POSTER
Astrum-005 Extended Follow-Up Results
ASTRIDE ASCO 2025 POSTER
Serplulimab versus placebo plus chemotherapy as first-line treatment for extensive stage small cell lung cancer: efficacy and safety from the end-of-study analysis of the international phase 3 ASTRUM-005 study.
Serplulimab is an investigational therapy in the US and is not FDA approved. The ASTRUM-005 trial provides important research on its potential treatment for ES-SCLC.
ES-SCLC=extensive-stage small cell lung cancer.
ABOUT FOSUN PHARMA
Fosun Pharma USA Inc. was established in 2017, with headquarters in Princeton, New Jersey. Fosun Pharma USA Inc. is a wholly owned subsidiary of Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun HQ”). Fosun HQ, founded in 1994 and headquartered in Shanghai, is a top global, innovation-driven pharmaceutical and healthcare industry group.
As a U.S.-focused specialty pharmaceutical company, Fosun Pharma USA:
- Innovates through strategic partnerships and building its commercial presence in the United States
- Advances innovative products to patients in need by leveraging its global parent company, Fosun Pharma Group, as well as a unique R&D model
- Is led by a team of highly experienced executives, who have a strong track record as leaders at both U.S. and European-based pharma companies, in both commercial operations and R&D
- Currently maintains a portfolio comprised of specialty pharmaceutical injectables and ophthalmics and intends to build a portfolio of high-value, innovative brands
Fosun Pharma USA continues to build its pipeline with late development stage (phase 2 and beyond) or commercial stage innovative products dedicated to the U.S. market. While Fosun Pharma USA can facilitate a partnership with Fosun HQ for the Chinese market, the focus is on U.S. rights for innovative biopharmaceutical products. Website: www.fosunpharmausa.com; Follow us on LinkedIn for more company updates: Fosun Pharma USA Inc.
